GDF2 and pulmonary arterial hypertension: A study identified ATPase 13A3 (ATP13A3) variants as one of the most frequent genetic contributors to PAH in Asian cohorts, alongside BMPR2 and growth differentiation factor 2 (GDF2) [53].